Search Results for: thalassemia

CTX001

CTX001 is an investigational therapy that CRISPR Therapeutics is developing to treat inherited disorders of hemoglobin such as sickle cell anemia and beta-thalassemia. How CTX001 works Sickle cell anemia is caused by ... Read more